Meningococcal diseases in Austria;Meningokokkenerkrankungen in Osterreich

Wiener Klinische Wochenschrift

Volumn 110, Issue 12, 1998, Pages 415-422

  Thiel, Werner ^a,b   Haas, Gertrude ^a   Heuberger, Sigrid ^a  

^a Untersuchungsanstalt Graz ^*  (Austria)

^b Meningokokken Zentrale   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PENICILLIN G; RIFAMPICIN;

ADOLESCENT; ADULT; AUSTRIA; CHEMOPROPHYLAXIS; CHILD; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; INFECTION RATE; MALE; MENINGOCOCCOSIS; PLEURISY; SEPSIS; SHORT SURVEY;

ADOLESCENT; ADULT; AGED; AUSTRIA; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; CONTACT TRACING; CROSS-SECTIONAL STUDIES; DISEASE NOTIFICATION; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; SEROTYPING;

EID: 0032569085     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (27)

1. e année, N 145
2. Thiel W (1980) Anmerkungen zum Thema Epidemiologie. Mitteilungen der Österr. Sanitätsverwaltung, Heft 4
3. Ambrosch F, Stanck G (1980) Die Epidemiologie der Meningokokken-Meningitis in Österreich. Wien Med Wochenschr 130: 177-183
4. Thiel W, Haas G, Fox A, Caugant DA (1994) Epidemiology of Neisseria meningitidis in Austria. Antibiotika Monitor tom 1/2: 13-15
5. Allerberger F, Eigentier A, Dierich MP (1992) Subtyping meningococci. Lancet 339: 125
6. Eigentlicher A, Allerberger F, Thiel W, Dierich MP (1991) Epidemiologische Untersuchungen über Meningokokkenerkrankungen im Bundesland Tirol, Abstract, 43. Tagung der Deutschen Gesellschaft für Hygiene und Mikrobiologie
7. Eigentier A, Berthelsen L, Dierich, MP, Lind I (1994) Meningococcal disease in Tyrol: application of multilocus enzyme electrophoresis and DN-fingerprinting to the epidemioiogical investigation of Neisseria meningitidis serogroup-B isolates. Alpe Adna Microbiology J 3: 195-204
8. Erlaß des BMGSK, Zl. 21.700/30-II/D/2/96
9. Berichte der Meningokokken-Zentrale für 1994, 1995
10. European monitoring-group on meningococci (1994) 1st Meeting, Graz, Austria, May 14-15th, 1993. Antibiotika Monitor tom X 1/2
11. Thiel W, Fox AJ and participants in the EMGM, Meningococcal disease in Europe: concerted action on all aspects of disease management. Poster 130. The Ninth International Pathogenic Neisseria Conference 1994, Winchester, England
12. Connolly M, Noah N (1996, 1997) King's European Meningitis Surveillance Unit. Surveillance of bacterial meningitis in Europe 1995, 1996. King's College School of Medicine & Dentistry
13. Hubert B, Caugant DA (1997) Recent changes in meningococcal disease in Europe. Eurosurvcillance 2/10: 69-71
14. Kriz P, Vlckova J, Bobak M (1995) Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republik. Epidemiol Infect 115: 411-418
15. Jackson LA, Schuchat A, Reeves MW, Wenger JD (1995) Serogroup C meningococcal outbreaks in the United States. An emerging threat. JAMA 273: 383-389
16. Untersuchung eines Ausbruches von Meningokokkenerkrankungen in Niederbayern (1998) Epidemiologisches Bulletin 10/98, RKI (Robert Koch Institut), 13. 3. 1998, S 65-66
17. Control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks: recommendations of the advisory committee on immunization practices (ACIP), (1997) MMWR 46: No. RR-5
18. Stuart JM, Monk PN, Lewis DA, Constantine C, Kaczmarski EB, Cartwright KAV (on behalf of the PHLS Meningococcus Working Group and Public Health Medicine Environmental Group) (1997) Management of clusters of meningococcal disease. Commun Dis Rep 7 (Rev No. 1): R 3-R 4
19. Thalanany M (1997) Management of clusters of meningococcal disease. Survey of 35 European Countries. In: Connolly M, Noah N (eds.) Surveillance of bacterial meningitis in Europe 1996. King's College School of Medicine & Dentistry pp 34-40
20. Eigentler A, Dierich MP (1992) Meningokokkenerkrankungen: Spezielle Hygiene nötig. Österr Ärztezeitung 17: 29-31
21. Borrow R, Claus H, Quiver M, Smart L, Jones DM, Kaczmarski EB, Frosch M, Fox AJ (1997) Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialyltransferase (siaD) PCR ELISA. Epidemiol Infect 118: 111-117
22. Kaczmarski EB, Ragunathan PL, Marsh J, Gray SJ, Guiver M (1998) Creating a national service for the diagnosis of meningococcal disease by polymerase chain reaction. Communie Disease Public Health 1: 54-56
23. Heuberger S, Schlager S, Hausdorfer H, Thiel W (1997) Diagnosis of bacterial meningitis in CSF using PCR and DNA enzyme-immunoassay. EMGM 4th Meeting, Institut Pasteur Paris, Juni 4th-7th, 1997
24. Kubin R (1993) Safety and efficacy of ciprofloxacin in paediatric patients. Infection 21: 413-421
25. Frasch CE (1995) Meningococcal vaccines: past, present and future. In: Cartwright K (ed) Meningococcal disease. John Wiley & Sons, New York
26. Poolman J, Cartwright K, Morris R, Rumke H, Fox AF, Borrow R, Begg N, Miller E (1997) Phase 2 study of a novel meningococcal vaccine containing multiple class 1 outermembrane proteins. EMGM 4th Meeting. Institut Pasteur Paris, June 4th-7th, 1997
27. Herbert MA, Heath PT, Mayon-White RT (1995) Meningococcal vaccines for the United Kingdom. CDR 5 (Review No 9) R 130-R 135